Your browser doesn't support javascript.
loading
Comparison of anti-reflux mechanism between Double-J-Stent and standart Double-J-Stent use for risk of BK nephropathy and urinary tract Infection in kidney transplantation.
Ay, Nurettin; Bahadir, Mehmet Veysi; Anil, Melih; Alp, Vahhac; Kaya, Safak; Sevük, Utkan; Gül, Mesut; Danis, Ramazan.
Afiliación
  • Ay N; Diyarbakir Education and Research Hospital, Transplantation Center Diyarbakir, Turkey.
  • Bahadir MV; Department of General Surgery, Dicle University Education and Research Hospital Diyarbakir, Turkey.
  • Anil M; Department of Nephrology, Diyarbakir Gazi Yasargil Education and Research Hospital Diyarbakir, Turkey.
  • Alp V; Diyarbakir Education and Research Hospital, Transplantation Center Diyarbakir, Turkey.
  • Kaya S; Department of Infectious Disease, Diyarbakir Gazi Yasargil Training and Research Hospital Diyarbakir, Turkey.
  • Sevük U; Department of Cardiovascular Surgery, Diyarbakir Gazi Yasargil Education and Research Hospital Diyarbakir, Turkey.
  • Gül M; Department of General Surgery, Dicle University Education and Research Hospital Diyarbakir, Turkey.
  • Danis R; Department of Nephrology, Diyarbakir Gazi Yasargil Education and Research Hospital Diyarbakir, Turkey.
Int J Clin Exp Med ; 8(9): 16340-5, 2015.
Article en En | MEDLINE | ID: mdl-26629154
ABSTRACT

OBJECTIVES:

There are studies that show that double J stenting (DJS) increase BK nephropathy (BKN) 4 fold. DJS may cause vesicoureteral reflux (VUR) with normal bladder contraction. The aim of this study is to comparison risk of BKN, urinary tract infections (UTI) and postoperative urologic complications with the use DJS with anti-reflux device (ARD-DJS) and standart double J stent (St-DJS). Matherial and

methods:

Ninety patients (male/female 50/40) that had undergone kidney transplantations in Diyarbakir Training and Research Hospital and Dicle University, Faculty of Medicine Hospital between January 2012 and April 2015 were enrolled in the study. Demographic data, immunosuppression protocols, presence of rejection, graft loss, postoperative urologic complications, UTI, plasma BK levels of the patients were evaluated retrospectively.

RESULTS:

Median and IQR follow up time for ARD-DJS and St-DJS patients were 14 (12-18) months and 25 (16-30) months respectively. Five cases (5.5%) had BK viremia (P=0.025). All 5 cases with BK viremia were St-DJS users.

CONCLUSION:

As a result for postoperative UTI and postoperative urinary complication risk there were no statistically significant difference between ARD-DJS use and St-DJS use during ureteral anastomosis. BKN univariate analysis were significantly less than those st-DJS used. Risc factors were evaluated. But results were not statistically significant in the logistic regression analysis. We think that to demonstrate this benefit, we need randomized controlled studies with more patients and longer follow up.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Int J Clin Exp Med Año: 2015 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Int J Clin Exp Med Año: 2015 Tipo del documento: Article País de afiliación: Turquía